My Reta
Retaklik 40mg research peptide pen
Lab Tested 99%+
Retaklik 40mg · Apex Pharma

Research Use Only. Sourced from APEX Pharma & Genesis Labs. Not for human consumption, medical use, diagnosis, or treatment.

Apex Pharma · Retatrutide

Buy Retaklik 40mg UK

Retaklik 40mg is Apex Pharma's retatrutide (LY3437943) research peptide — a synthetic triple-receptor agonist for GLP-1, GIP, and glucagon pathways. Independently verified to ≥99% purity by Janoshik Analytical. Every order ships with a tamper-evident hologram and batch-specific COA.

£165In Stock
Secure Stripe PaymentUK Next Day Delivery

Strength

40mg

Compound

Retatrutide

Purity

≥99%

Format

Research Pen

Testing

Janoshik HPLC/MS

Delivery

Next Day UK

Third-Party COA

Every batch verified by Janoshik Analytical

Hologram Verified

Tamper-evident hologram + batch-code verification

Next Day UK

Royal Mail Tracked, discreet packaging

Secure Stripe PaymentUK Next Day Delivery

Analytical Verification & COA Reports

All Retaklik 40mg batches from APEX Pharma and Genesis Labs are independently lab-verified for purity and sterility. View verified reports below:

Retaklik 40mg Research Specifications

Active CompoundRetatrutide (LY3437943)
Strength40mg per pen
Sequence FormulaC₂₂₁H₃₄₂N₅₆O₆₈S₂
Molecular Weight4,731.3 g/mol
Purity (HPLC/MS)≥99.2% verified
Storage−20°C (lyophilised), 2–8°C (reconstituted)

Dose Conversion Reference

Retaklik 40mg Click Guide

Official visual reference for converting target retatrutide research doses (mg) into exact pen clicks on the Retaklik 40mg pen. 1mg increase = 8 clicks.

Retatrutide 40mg Pen Click Guide and Dose Conversion Chart

Also Available — The Upgraded Formula

Retaklik 2.0 44mg

Retaklik 2.0 — 44mg

The next-generation combination formula: retatrutide + cagrilintide in a single pen. Higher total dose, dual-pathway research potential.

£180
View Retaklik 2.0 — The Upgraded Formula

Latest Retatrutide & Retaklik Research Articles

Categories: Retatrutide • Retaklik • Reta

View All News →
Retatrutide TRIUMPH Results: Phase 3 Weight-Loss & Diabetes Data (2026)
15 July 20267 min read

Retatrutide TRIUMPH Results: Phase 3 Weight-Loss & Diabetes Data (2026)

Retatrutide’s 2026 Phase 3 data explained simply: TRIUMPH-1 delivered 28.3% mean weight loss at 80 weeks (45.3% lost 30%+), TRANSCEND-T2D-1 cut HbA1c up to 1.94%, plus knee and sleep-apnoea results. Still investigational — research use only.

Read Full Article →
How to Inject Retaklik and Retatrutide: comparison of injection pens vs vials for research use, featuring MyReta Medical Research Peptides branding and peptide administration guide.
3 July 202615 min read

How to Inject Retaklik / Retatrutide: The No-Mess UK Guide (Pens vs Vials)

Retaklik pen vs retatrutide vial: a plain-English, occasionally funny UK guide to how injecting actually works, why pens skip the mess of reconstitution, and how standard Retaklik compares to Retaklik 2.0.

Read Full Article →
Retatrutide 40mg Pen UK hero image showing a branded research pen, product box, COA certificate, and UK medical research visuals.
22 June 202617 min read

Retatrutide 40mg Pen UK: Doses, Pen Guide, Price & COA (2026)

What a retatrutide 40mg pen really is, what the 40mg buys you, how many doses it holds, how long it lasts, pen vs vial, a fair UK price, and how to check yours is genuine with a batch COA, hologram and unique batch code. Research use only.

Read Full Article →
How to Reconstitute Retatrutide: Step-by-Step UK Guide (2026)
22 June 20266 min read

How to Reconstitute Retatrutide: Step-by-Step UK Guide (2026)

A clear, step-by-step UK guide to reconstituting retatrutide for research: what you need, the exact mixing order, the swirl-don’t-shake rule, storage stability, troubleshooting, and a free calculator to do the maths. Research use only.

Read Full Article →
Retatrutide Weight Loss Results: What the Clinical Trials Actually Show (2026)
22 June 20267 min read

Retatrutide Weight Loss Results: What the Clinical Trials Actually Show (2026)

Retatrutide produced up to 24.2% mean weight loss in Eli Lilly’s Phase 2 trial — and it hadn’t plateaued. Here’s exactly what the clinical data shows, how it compares to semaglutide and tirzepatide, and the UK research context.

Read Full Article →
Retaklik vs Retatrutide: Are They the Same Thing? (UK Guide 2026)
14 June 20266 min read

Retaklik vs Retatrutide: Are They the Same Thing? (UK Guide 2026)

Retaklik and retatrutide get used interchangeably, but they’re not the same word — and Retaklik 2.0 isn’t even pure retatrutide. Here’s the plain-English UK explainer on what each term means and what to check before you buy.

Read Full Article →

Retaklik 40mg — Frequently Asked Questions

What is Retaklik 40mg?

Retaklik 40mg is Apex Pharma's branded retatrutide (LY3437943) research peptide — a synthetic triple-receptor agonist acting on GLP-1, GIP, and glucagon receptors. Supplied strictly for laboratory and in vitro research use.

Is Retaklik 40mg the same as retatrutide?

Yes. Retaklik is a trade name used by Apex Pharma for retatrutide-based research peptides. The active compound is the same molecule — retatrutide.

What is the difference between Retaklik 40mg and Retaklik 2.0 44mg?

Retaklik 40mg contains retatrutide only. Retaklik 2.0 44mg combines retatrutide and cagrilintide for a higher total dose in a single pen, offering dual-pathway research potential.

How do I verify my Retaklik batch?

Every My Reta order includes a tamper-evident hologram. Check the batch code against the Janoshik Analytical report published on our COA page.

Can I buy Retaklik 40mg in the UK?

Yes. My Reta supplies Retaklik 40mg research peptides from the UK with next-day delivery. For laboratory and research use only — not for human consumption.